Distribution partnership with MBA SURGICAL EMPOWERMENT

MBA SURGICAL EMPOWERMENT, a leading Spanish distributor in the medical-surgical technology sector, has partnered with Marginum.

MBA SURGICAL EMPOWERMENT, a leading Spanish distributor in the medical-surgical technology sector, has partnered with Marginum.

Marginum Ltd has initiated its first-in-human clinical trials with the aspirate tissue monitor at the Kuopio University Hospital.

Tahko Ski Lift Pitch winner Marginum is pioneering optic tissue monitoring with groundbreaking innovation borne from multidisciplinary UEF research.

Marginum joins Kuopio Chamber of Commerce and the Finnish Startup Community after winning Tahko Ski Lift Pitch 2022.

Marginum has been nominated by University of Eastern Finland (UEF) to participate at Stage Two competition in Berlin.

Marginum joined Kuopio Health to further connect with research institutions and other member companies in the medical technology industry.

Cancerous tissue could be completely removed in the first operation. In this story, we’ll tell you what Marginum’s device is all about.

Marginum Ltd, founded in autumn 2020, is developing next-generation technology for the removal of cancerous tumours.

Precision techniques such as Marginum’s aspirate tissue monitoring enable unprecedently efficient identification of cancer tissue and the best possible treatment.

Contemporary techniques in glioma surgery are limited by their complexity, subjectivity and randomness, resulting in reoperations and suboptimal care.